Sean Bundy

Sean Bundy currently serves as the Vice President of Regulatory Affairs & Quality Assurance at Foundation Medicine since October 2025. Prior to this role, Bundy held the position of Vice President of Quality and Regulatory Affairs at NeoGenomics Laboratories from November 2022 to October 2025 and was the Chief Operating Officer at HepQuant from July 2018 to November 2022. Bundy's experience also includes key leadership roles in regulatory and quality affairs at Precision Biopsy, LLC, and Cochlear, where responsibilities encompassed managing teams, overseeing regulatory submissions, and ensuring quality system compliance. Sean Bundy holds an MBA from Edinburgh Business School and has specialized qualifications in Medical Technology Regulatory Affairs from Cranfield University, along with a Postgraduate Certificate in Clinical Studies Management from the University of Chicago.